A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.
Fatih GürlerFatih TayZehra Sucuoglu IsleyenTahir YerlikayaHaci Mehmet TurkSelin Aktürk EsenOsman SütçüoğluDeniz IşıkBüşra NiğdelioğluMiraç ÖzenElif SahinTeoman SakalarNilay Sengul SamanciÖzkan Alanİlhan HacıbekiroğluEfnan AlginMelek Karakurt YılmazHacı Mehmet TürkÖmür Berna Çakmak ÖksüzoğluAydın YavuzOsman YukselHüseyin BoraOzan YazıcıAhmet ÖzetNuriye OzdemirPublished in: Cancer medicine (2024)
Favorable PFS and pCR rates and a comparable OS were obtained with the CROSS regimen over the CF regimen as neoadjuvant chemoradiotherapy in patients with ESCC.